Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 497

1.

Point-of-care biomarkers in asthma management: time to move forward.

Alving K, Diamant Z, Lucas S, Magnussen H, Pavord ID, Piancentini G, Price D, Roche N, Sastre J, Thomas M, Usmani O, Bjermer L; Respiratory Effectiveness Group, Biomarkers Working Group.

Allergy. 2019 Sep 10. doi: 10.1111/all.14045. [Epub ahead of print]

PMID:
31505025
2.

Genuair®/Pressair® Inhaler in COPD: The Patient Perspective.

Magnussen H, Fyrnys B, Greguletz R.

COPD. 2019 Apr;16(2):196-205. doi: 10.1080/15412555.2019.1630807. Epub 2019 Jul 2.

PMID:
31264482
3.

[Therapy control of COPD by Eosinophilic Granulocytes?]

Magnussen H.

Dtsch Med Wochenschr. 2019 Jul;144(13):917-921. doi: 10.1055/a-0748-8856. Epub 2019 Jun 28. German.

PMID:
31252446
4.

Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial.

Watz H, Tetzlaff K, Magnussen H, Mueller A, Rodriguez-Roisin R, Wouters EFM, Vogelmeier C, Calverley PMA.

Respir Res. 2018 Dec 13;19(1):251. doi: 10.1186/s12931-018-0944-3.

5.

[Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology].

Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, Gillissen A, Greulich T, Haidl P, Hamelmann E, Kardos P, Kenn K, Klimek L, Korn S, Lommatzsch M, Magnussen H, Nicolai T, Nowak D, Pfaar O, Rabe KF, Riedler J, Ritz T, Schultz K, Schuster A, Spindler T, Taube C, Taube K, Vogelmeier C, von Leupoldt A, Wantke F, Weise S, Wildhaber J, Worth H, Zacharasiewicz A.

Pneumologie. 2017 Dec;71(12):e3. doi: 10.1055/a-0790-0021. Epub 2018 Nov 7. German. No abstract available.

PMID:
30406626
6.

The Effect of Defining Chronic Obstructive Pulmonary Disease by the Lower Limit of Normal of the FEV1/FVC Ratio.

Fragoso CAV, Magnussen H, Miller MR, Brusasco V.

Ann Am Thorac Soc. 2018 Jun;15(6):766-767. doi: 10.1513/AnnalsATS.201802-109LE. No abstract available.

PMID:
29557668
7.

[Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology].

Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, Gillissen A, Greulich T, Haidl P, Hamelmann E, Kardos P, Kenn K, Klimek L, Korn S, Lommatzsch M, Magnussen H, Nicolai T, Nowak D, Pfaar O, Rabe KF, Riedler J, Ritz T, Schultz K, Schuster A, Spindler T, Taube C, Taube K, Vogelmeier C, von Leupold A, Wantke F, Weise S, Wildhaber J, Worth H, Zacharasiewicz A.

Pneumologie. 2017 Dec;71(12):e2. doi: 10.1055/s-0044-100881. Epub 2018 Jan 15. German. No abstract available.

PMID:
29334688
8.

[Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology].

Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin e. V; Deutsche Gesellschaft für Rehabilitationswissenschaften e.V; und Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e.V.;, Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, Gillissen A, Greulich T, Haidl P, Hamelmann E, Kardos P, Kenn K, Klimek L, Korn S, Lommatzsch M, Magnussen H, Nicolai T, Nowak D, Pfaar O, Rabe KF, Riedler J, Ritz T, Schultz K, Schuster A, Spindler T, Taube C, Taube K, Vogelmeier C, von Leupoldt A, Wantke F, Weise S, Wildhaber J, Worth H, Zacharasiewicz A.

Pneumologie. 2017 Dec;71(12):849-919. doi: 10.1055/s-0043-119504. Epub 2017 Dec 7. German. Erratum in: Pneumologie. 2017 Dec;71(12 ):e2. Taube, R C [corrected to Taube, C]. Pneumologie. 2017 Dec;71(12):e3.

9.

Physical Activity and Fatigue in Patients with Sarcoidosis.

Bahmer T, Watz H, Develaska M, Waschki B, Rabe KF, Magnussen H, Kirsten D, Kirsten AM.

Respiration. 2018;95(1):18-26. doi: 10.1159/000481827. Epub 2017 Nov 9.

10.

Triple Therapy in COPD: What We Know and What We Don't.

Calverley PMA, Magnussen H, Miravitlles M, Wedzicha JA.

COPD. 2017 Dec;14(6):648-662. doi: 10.1080/15412555.2017.1389875. Epub 2017 Nov 9. Review.

PMID:
29120273
11.

Spirometry Variability Must Be Critically Interpreted before Negating a Clinical Diagnosis of Chronic Obstructive Pulmonary Disease.

Magnussen H, Vaz Fragoso CA, Miller MR, Brusasco V.

Am J Respir Crit Care Med. 2018 Mar 15;197(6):835-836. doi: 10.1164/rccm.201709-1815LE. No abstract available.

PMID:
29106291
12.

Spirometry-based Diagnostic Criteria That Are Not Age-Appropriate Lack Clinical Relevance.

Vaz Fragoso CA, Magnussen H, Miller MR, Brusasco V.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):963-964. doi: 10.1164/rccm.201709-1789LE. No abstract available.

PMID:
29096065
13.

Brain Activation during Perception and Anticipation of Dyspnea in Chronic Obstructive Pulmonary Disease.

Esser RW, Stoeckel MC, Kirsten A, Watz H, Taube K, Lehmann K, Magnussen H, Büchel C, von Leupoldt A.

Front Physiol. 2017 Aug 23;8:617. doi: 10.3389/fphys.2017.00617. eCollection 2017.

14.

What can we learn from pulmonary function testing in heart failure?

Magnussen H, Canepa M, Zambito PE, Brusasco V, Meinertz T, Rosenkranz S.

Eur J Heart Fail. 2017 Oct;19(10):1222-1229. doi: 10.1002/ejhf.946. Epub 2017 Aug 14. Review.

15.

Physical activity patterns and clusters in 1001 patients with COPD.

Mesquita R, Spina G, Pitta F, Donaire-Gonzalez D, Deering BM, Patel MS, Mitchell KE, Alison J, van Gestel AJ, Zogg S, Gagnon P, Abascal-Bolado B, Vagaggini B, Garcia-Aymerich J, Jenkins SC, Romme EA, Kon SS, Albert PS, Waschki B, Shrikrishna D, Singh SJ, Hopkinson NS, Miedinger D, Benzo RP, Maltais F, Paggiaro P, McKeough ZJ, Polkey MI, Hill K, Man WD, Clarenbach CF, Hernandes NA, Savi D, Wootton S, Furlanetto KC, Cindy Ng LW, Vaes AW, Jenkins C, Eastwood PR, Jarreta D, Kirsten A, Brooks D, Hillman DR, Sant'Anna T, Meijer K, Dürr S, Rutten EP, Kohler M, Probst VS, Tal-Singer R, Gil EG, den Brinker AC, Leuppi JD, Calverley PM, Smeenk FW, Costello RW, Gramm M, Goldstein R, Groenen MT, Magnussen H, Wouters EF, ZuWallack RL, Amft O, Watz H, Spruit MA.

Chron Respir Dis. 2017 Aug;14(3):256-269. doi: 10.1177/1479972316687207. Epub 2017 Feb 24.

16.

Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis.

Bahmer T, Kirsten AM, Waschki B, Rabe KF, Magnussen H, Kirsten D, Gramm M, Hummler S, Brunnemer E, Kreuter M, Watz H.

BMC Pulm Med. 2017 Jul 25;17(1):104. doi: 10.1186/s12890-017-0444-0.

17.

Aclidinium bromide improves symptoms and sleep quality in COPD: a pilot study.

Magnussen H, Arzt M, Andreas S, Plate T, Ribera A, Seoane B, Watz H, Kirsten AM.

Eur Respir J. 2017 Jun 22;49(6). pii: 1700485. doi: 10.1183/13993003.00485-2017. Print 2017 Jun. No abstract available.

18.

Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.

Waschki B, Watz H, Holz O, Magnussen H, Olejnicka B, Welte T, Rabe KF, Janciauskiene S.

Int J Chron Obstruct Pulmon Dis. 2017 Mar 22;12:981-987. doi: 10.2147/COPD.S128689. eCollection 2017.

19.

Eosinophilia, Frequent Exacerbations, and Steroid Response in Chronic Obstructive Pulmonary Disease.

Calverley PMA, Tetzlaff K, Vogelmeier C, Fabbri LM, Magnussen H, Wouters EFM, Mezzanotte W, Disse B, Finnigan H, Asijee G, Hallmann C, Watz H.

Am J Respir Crit Care Med. 2017 Nov 1;196(9):1219-1221. doi: 10.1164/rccm.201612-2525LE. No abstract available.

PMID:
28306321
20.

Analysis of nocturnal actigraphic sleep measures in patients with COPD and their association with daytime physical activity.

Spina G, Spruit MA, Alison J, Benzo RP, Calverley PMA, Clarenbach CF, Costello RW, Donaire-Gonzalez D, Dürr S, Garcia-Aymerich J, van Gestel AJR, Gramm M, Hernandes NA, Hill K, Hopkinson NS, Jarreta D, Kohler M, Kirsten AM, Leuppi JD, Magnussen H, Maltais F, Man WD, McKeough ZJ, Mesquita R, Miedinger D, Pitta F, Singh SJ, Smeenk FWJM, Tal-Singer R, Vagaggini B, Waschki B, Watz H, Wouters EFM, Zogg S, den Brinker AC.

Thorax. 2017 Aug;72(8):694-701. doi: 10.1136/thoraxjnl-2016-208900. Epub 2017 Jan 12.

21.

Angiopoietin-like protein 4 and cardiovascular function in COPD.

Waschki B, Kirsten AM, Holz O, Meyer T, Lichtinghagen R, Rabe KF, Magnussen H, Welte T, Watz H, Janciauskiene S.

BMJ Open Respir Res. 2016 Oct 31;3(1):e000161. eCollection 2016.

22.

Linkage between Fitness of Yeast Cells and Adenylate Kinase Catalysis.

Tükenmez H, Magnussen HM, Kovermann M, Byström A, Wolf-Watz M.

PLoS One. 2016 Sep 19;11(9):e0163115. doi: 10.1371/journal.pone.0163115. eCollection 2016.

23.

Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease.

Rodriguez-Roisin R, Tetzlaff K, Watz H, Wouters EF, Disse B, Finnigan H, Magnussen H, Calverley PM.

Int J Chron Obstruct Pulmon Dis. 2016 Aug 22;11:1973-81. doi: 10.2147/COPD.S106142. eCollection 2016.

24.

Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences-Comorbidities Network Study.

Houben-Wilke S, Jörres RA, Bals R, Franssen FM, Gläser S, Holle R, Karch A, Koch A, Magnussen H, Obst A, Schulz H, Spruit MA, Wacker ME, Welte T, Wouters EF, Vogelmeier C, Watz H.

Am J Respir Crit Care Med. 2017 Jan 15;195(2):189-197. doi: 10.1164/rccm.201602-0354OC.

PMID:
27532739
25.

Clinical Correlates of Reduced Physical Activity in Idiopathic Pulmonary Fibrosis.

Bahmer T, Kirsten AM, Waschki B, Rabe KF, Magnussen H, Kirsten D, Gramm M, Hummler S, Brunnemer E, Kreuter M, Watz H.

Respiration. 2016;91(6):497-502. doi: 10.1159/000446607. Epub 2016 Jun 1.

26.

Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.

Watz H, Tetzlaff K, Wouters EF, Kirsten A, Magnussen H, Rodriguez-Roisin R, Vogelmeier C, Fabbri LM, Chanez P, Dahl R, Disse B, Finnigan H, Calverley PM.

Lancet Respir Med. 2016 May;4(5):390-8. doi: 10.1016/S2213-2600(16)00100-4. Epub 2016 Apr 7.

PMID:
27066739
27.

Reduced physical activity in lymphangioleiomyomatosis compared with COPD and healthy controls: disease-specific impact and clinical correlates.

Bahmer T, Watz H, Waschki B, Gramm M, Magnussen H, Rabe KF, Wirtz H, Kirsten D, Kirsten A.

Thorax. 2016 Jul;71(7):662-3. doi: 10.1136/thoraxjnl-2015-207852. Epub 2016 Mar 11.

PMID:
26968971
28.

Current thinking and new paradigm for COPD.

Welte T, Chapman KR, Magnussen H, Miravitlles M.

Respir Med. 2016 Mar;112:126-7. doi: 10.1016/j.rmed.2015.10.014. Epub 2016 Jan 13.

29.

[Assessment and management of breathlessness, cancer pain, constipation and depression in patients with incurable cancer].

Pralong A, Bausewein C, Magnussen H, Radbruch L, Meißner W, Becker G, Holtmann M, Perrar KM, Fegg M, Voltz R, Simon ST.

MMW Fortschr Med. 2016 Jan;158(1):35-39. doi: 10.1007/s15006-016-7698-y. German. No abstract available.

PMID:
28924768
30.

Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD.

Magnussen H, Tetzlaff K, Bateman ED, Watz H, Kirsten AM, Wouters EF, Disse B, Finnigan H, Rodriguez-Roisin R, Calverley PM.

Eur Respir J. 2016 Feb;47(2):651-4. doi: 10.1183/13993003.01644-2015. Epub 2015 Nov 19. No abstract available.

31.

In memoriam Prof. Dr. Hans-Nikol Hubertus Macha.

Magnussen H.

Pneumologie. 2015 Nov;69(11):680-1. doi: 10.1055/s-0035-1563757. Epub 2015 Nov 6. German. No abstract available.

32.

Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patients.

Pedersen F, Marwitz S, Holz O, Kirsten A, Bahmer T, Waschki B, Magnussen H, Rabe KF, Goldmann T, Uddin M, Watz H.

Respir Med. 2015 Oct;109(10):1360-2. doi: 10.1016/j.rmed.2015.08.008. Epub 2015 Aug 22.

33.

[Dyspnea. Profile of the most important diagnostic tests].

Abolmaali N, Foelske H, Magnussen H, Palisch H, Schellong SM.

Internist (Berl). 2015 Aug;56(8):872-81. doi: 10.1007/s00108-015-3687-y. Review. German.

PMID:
26219618
34.

Structural Brain Changes in Patients With COPD.

Esser RW, Stoeckel MC, Kirsten A, Watz H, Taube K, Lehmann K, Petersen S, Magnussen H, von Leupoldt A.

Chest. 2016 Feb;149(2):426-434. doi: 10.1378/chest.15-0027. Epub 2016 Jan 12.

PMID:
26203911
35.

Disease Progression and Changes in Physical Activity in Patients with Chronic Obstructive Pulmonary Disease.

Waschki B, Kirsten AM, Holz O, Mueller KC, Schaper M, Sack AL, Meyer T, Rabe KF, Magnussen H, Watz H.

Am J Respir Crit Care Med. 2015 Aug 1;192(3):295-306. doi: 10.1164/rccm.201501-0081OC.

PMID:
26020495
36.

[Standardization of spirometry: 2015 update. Published by German Atemwegsliga, German Respiratory Society and German Society of Occupational and Environmental Medicine].

Criée CP, Baur X, Berdel D, Bösch D, Gappa M, Haidl P, Husemann K, Jörres RA, Kabitz HJ, Kardos P, Köhler D, Magnussen H, Merget R, Mitfessel H, Nowak D, Ochmann U, Schürmann W, Smith HJ, Sorichter S, Voshaar T, Worth H.

Pneumologie. 2015 Mar;69(3):147-64. doi: 10.1055/s-0034-1391345. Epub 2015 Mar 6. German.

37.

CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease.

Rennard SI, Dale DC, Donohue JF, Kanniess F, Magnussen H, Sutherland ER, Watz H, Lu S, Stryszak P, Rosenberg E, Staudinger H.

Am J Respir Crit Care Med. 2015 May 1;191(9):1001-11. doi: 10.1164/rccm.201405-0992OC.

PMID:
25695403
38.

Inhaled glucocorticoids and COPD exacerbations.

Magnussen H, Tetzlaff K, Calverley PM.

N Engl J Med. 2015 Jan 1;372(1):93-4. doi: 10.1056/NEJMc1413308. No abstract available.

PMID:
25551535
39.

Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial.

Beeh KM, Watz H, Puente-Maestu L, de Teresa L, Jarreta D, Caracta C, Garcia Gil E, Magnussen H.

BMC Pulm Med. 2014 Dec 23;14:209. doi: 10.1186/1471-2466-14-209.

40.

Longitudinal measurement of airway inflammation over one year in children and adults with intermittent asthma.

Pedersen F, Holz O, Kanniess F, Zielen S, Schulze J, Gillissen A, von Berg A, Berdel D, Beier J, Beeh K, Schnoor M, Magnussen H.

BMC Res Notes. 2014 Dec 17;7:925. doi: 10.1186/1756-0500-7-925.

41.

Multi-analyte profiling of inflammatory mediators in COPD sputum--the effects of processing.

Pedersen F, Holz O, Lauer G, Quintini G, Kiwull-Schöne H, Kirsten AM, Magnussen H, Rabe KF, Goldmann T, Watz H.

Cytokine. 2015 Feb;71(2):401-4. doi: 10.1016/j.cyto.2014.10.008. Epub 2014 Nov 15.

PMID:
25464927
42.

An official European Respiratory Society statement on physical activity in COPD.

Watz H, Pitta F, Rochester CL, Garcia-Aymerich J, ZuWallack R, Troosters T, Vaes AW, Puhan MA, Jehn M, Polkey MI, Vogiatzis I, Clini EM, Toth M, Gimeno-Santos E, Waschki B, Esteban C, Hayot M, Casaburi R, Porszasz J, McAuley E, Singh SJ, Langer D, Wouters EF, Magnussen H, Spruit MA.

Eur Respir J. 2014 Dec;44(6):1521-37. doi: 10.1183/09031936.00046814. Epub 2014 Oct 30.

43.
44.

Withdrawal of inhaled glucocorticoids and exacerbations of COPD.

Magnussen H, Disse B, Rodriguez-Roisin R, Kirsten A, Watz H, Tetzlaff K, Towse L, Finnigan H, Dahl R, Decramer M, Chanez P, Wouters EF, Calverley PM; WISDOM Investigators.

N Engl J Med. 2014 Oct 2;371(14):1285-94. doi: 10.1056/NEJMoa1407154. Epub 2014 Sep 8.

45.

Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma--an exploratory study.

Kirsten AM, Watz H, Brindicci C, Piccinno A, Magnussen H.

Pulm Pharmacol Ther. 2015 Apr;31:79-84. doi: 10.1016/j.pupt.2014.08.007. Epub 2014 Sep 4.

PMID:
25194884
46.

[Statement to long term oxygen therapy].

Magnussen H, Hauck RW, Worth H, Herth FJ.

Pneumologie. 2014 Sep;68(9):591-3. doi: 10.1055/s-0034-1377329. Epub 2014 Jul 21. German. No abstract available.

47.

Current evidence and future research needs for FeNO measurement in respiratory diseases.

Bjermer L, Alving K, Diamant Z, Magnussen H, Pavord I, Piacentini G, Price D, Roche N, Sastre J, Thomas M, Usmani O.

Respir Med. 2014 Jun;108(6):830-41. doi: 10.1016/j.rmed.2014.02.005. Epub 2014 Feb 15. Review.

48.

Reprogramming of COPD lung fibroblasts through formation of induced pluripotent stem cells.

Basma H, Gunji Y, Iwasawa S, Nelson A, Farid M, Ikari J, Liu X, Wang X, Michalski J, Smith L, Iqbal J, El Behery R, West W, Yelamanchili S, Rennard D, Holz O, Mueller KC, Magnussen H, Rabe K, Castaldi PJ, Rennard SI.

Am J Physiol Lung Cell Mol Physiol. 2014 Mar 15;306(6):L552-65. doi: 10.1152/ajplung.00255.2013. Epub 2014 Jan 31.

49.

Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale.

Magnussen H, Watz H, Kirsten A, Decramer M, Dahl R, Calverley PM, Towse L, Finnigan H, Tetzlaff K, Disse B.

Respir Med. 2014 Apr;108(4):593-9. doi: 10.1016/j.rmed.2014.01.002. Epub 2014 Jan 15.

50.

[Bronchodilator therapy of COPD].

Kirsten AM, Watz H, Magnussen H.

Dtsch Med Wochenschr. 2014 Feb;139(6):264-7. doi: 10.1055/s-0033-1360019. Epub 2014 Jan 28. German. No abstract available.

PMID:
24473845

Supplemental Content

Loading ...
Support Center